The Interaction Potential of Retigabine (Ezogabine) with Other Antiepileptic Drugs

Publisher： Bentham Science Publishers

E-ISSN： 2212-3938|9|2|148-156

ISSN： 1574-8847

Source： Current Clinical Pharmacology, Vol.9, Iss.2, 2014-05, pp. : 148-156

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical Pharmacokinetics of Retigabine/Ezogabine

By  

Current Clinical Pharmacology, Vol. 8, Iss. 4, 2013-11 ,pp. : 319-331

Bentham Science Publishers

Access to resources Recommend Favorite

Safety profile of two novel antiepileptic agents approved for the treatment of refractory partial seizures: ezogabine (retigabine) and perampanel

By Faulkner Michele A   Burke Rachel A  

Expert Opinion on Drug Safety, Vol. 12, Iss. 6, 2013-11 ,pp. : 847-855

Informa Healthcare

Access to resources Recommend Favorite

Retigabine (Ezogabine): In Partial-Onset Seizures in Adults with Epilepsy

By Deeks Emma D.  

CNS Drugs, Vol. 25, Iss. 10, 2011-10 ,pp. : 887-900

Adis International

Access to resources Recommend Favorite

Interaction of topiramate with conventional antiepileptic drugs in mice

By Swiader M.   Kotowski J.   Gasior  

European Journal of Pharmacology, Vol. 399, Iss. 1, 2000-06 ,pp. : 35-41

Elsevier

Access to resources Recommend Favorite

Retigabine/Ezogabine, a KCNQ/KV7 channel opener: pharmacological and clinical data

By Orhan Gökce   Wuttke Thomas V   Nies Anne T   Schwab Matthias   Lerche Holger  

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 12, 2012-08 ,pp. : 1807-1816

Informa Healthcare

Access to resources Recommend Favorite